ReviewCurrent gene therapy2026

CRISPR/Cas9 Technology for Modifying Immune Checkpoint in CAR-T Cell Therapy for Hematopoietic Malignancies.

Forough Shams et al.PubMed ↗Publisher ↗

No numbers read from the abstract.